David Aanensen

Professor

University of Oxford
Country flagUnited Kingdom
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

BACKGROUND Ciprofloxacin resistant Klebsiella pneumoniae is common or emerging in many geographies, and knowledge of local resistance rates is important for empirical therapy. Whilst there are known K. pneumoniae ciprofloxacin resistance determinants, there is a lack of systematic data on the effect of determinants, alone and in combination, and there are no publicly accessible tools for predicting resistance from whole genome sequence data. METHODS The KlebNET-GSP AMR Genotype-Phenotype Group aggregated a matched genotype-phenotype dataset of n=12,167 K. pneumoniae species complex ( Kp SC) isolates from 27 countries between 2001-2021. We developed a rules-based classifier to predict ciprofloxacin resistance by categorizing the number of quinolone resistance determining regions mutations in gyrA and parC , the number of plasmid-mediated quinolone resistance genes, and the presence/absence of aac(6ʹ)-Ib-cr (which can acetylate ciprofloxacin). Predictive performance was assessed using the discovery dataset, for which we re-phenotyped discrepant isolates; and validated using externally contributed datasets (n=7,030 Kp SC isolates). RESULTS The rules-based classifier predicted R vs S/I with categorical agreement, sensitivity, and specificity >96%, and major/very major error rates <4%. Performance was similar across diverse Kp SC sources (human, animal, other), species, and intra-species lineages. External validation of the classifier yielded overall 93.12% categorical agreement [95% confidence interval (CI), 92.50-93.74%], 8.65% major errors [95% CI, 7.34-9.97%], and 6.20% very major errors [95% CI, 5.51-6.90%]. We implemented the classifier in Kleborate, a command-line tool that is integrated into the Pathogenwatch web platform. Using this to assess the global distribution of ciprofloxacin resistance determinants in Kp SC genomes available in Pathogenwatch (n=31,319, from 109 countries between years 2000-2023), we observed a significant positive association between national quinolone consumption rates and predicted ciprofloxacin resistance (R 2 =0.20, p=0.004). CONCLUSIONS Ciprofloxacin resistance phenotypes can be reasonably predicted from genotypes, which is sufficient for informing surveillance. However, unexplained resistance remains and accuracy is insufficient for clinical applications. We demonstrate the value of aggregating genotype-phenotype data to explore resistance mechanisms and develop predictors, but highlight complexities in combining phenotype data from different assays and standards.

Year:

2025

Enterobacter spp. are an important cause of healthcare-associated bloodstream infections uncommonly reported in Africa. This study used whole genome sequencing (WGS) to characterise Enterobacter spp. from hospitals in Nigeria’s antimicrobial resistance (AMR) surveillance system. Blood-culture isolates of Enterobacter from six such tertiary-care hospitals recovered between 2014 and 2020 were re-identified and antimicrobial susceptibility-tested using VITEK2. Illumina technology provided whole genome sequences for genome nomenclature, antimicrobial resistance gene prediction, Single Nucleotide Polymorphism (SNP) phylogeny, and multi-locus sequence typing via publicly available bioinformatics pipelines. Initial biochemical delineation often misclassified Enterobacter , necessitating whole-genome sequencing for accurate classification. Among 98 Enterobacter received, Enterobacter hormaechei subspecies xiangfangensis predominated (43), followed by other E. hormachei subspecies (18), E. cloacae (26), E. roggenkampii (4), E. bugandensis (3), E. kobei (2), E. asburiae (1) and E. cancerogenous (1). Cephalosporins, aminoglycoside, chloramphenicol, macrolide, and carbapenem resistance in E. hormaechei was attributed to known resistance genes. They belonged to clusters III, IV, and VIII based on hsp60 typing and clades A, B, C, and D according to Sutton and Co’s nomenclature. These isolates and other Enterobacter species recently reported from Nigeria reveal extensive E. hormaechei diversity, as well as clusters representing potential outbreaks . Enterobacter hormaechei , often misidentified and rarely reported from Nigeria, is this study’s most common blood culture isolated Enterobacter spp. Uncovering underappreciated species as important bloodstream pathogens and retrospective detection of likely outbreaks emphasise the value of genomic surveillance in resource-limited settings. DATA SUMMARY All sequence reads were submitted to the European Nucleotide Archive (ENA) under the project ID PRJEB29739 ( https://www.ebi.ac.uk/ena/browser/view/PRJEB29739 ). Accessions can be found in Table S1. IMPACT STATEMENT Accurate identification of Enterobacter is essential in healthcare settings as misidentification can lead to selecting antimicrobials to the genus is intrinsically resistant resistant before susceptibility testing results are available. Also, misidentification can compromise microbiology support for infection prevention and control. We show that E. hormaechei , which is never reported from clinical laboratories in Nigeria, is frequently misidentified using conventional methods like tube- or strip biochemical testing and VITEK systems. Whole genome sequence data demonstrates that E. hormaechei and E. cloacae are the most common Enterobacter isolated from bloodstream infections in Nigeria. Enhanced identification methods for surveillance play pivotal roles in improving patient care, optimising antibiotic stewardship, and combating the evolving challenges posed by this pathogen. Overall, this study reveals the effectiveness of WGS in correctly identifying this important pathogen.

Year:

2024

Klebsiella pneumoniae poses a significant healthcare challenge due to its multidrug resistance and diverse serotype landscape. This study aimed to explore the serotype diversity of 1072 K . pneumoniae and its association with geographical distribution, disease severity and antimicrobial/virulence patterns in India. Whole-genome sequencing was performed on the Illumina platform, and genomic analysis was carried out using the Kleborate tool. The analysis revealed a total of 78 different KL types, among which KL64 ( n =274/1072, 26 %), KL51 ( n =249/1072, 24 %), and KL2 ( n =88/1072, 8 %) were the most prevalent. In contrast, only 13 distinct O types were identified, with O1/O2v1 ( n =471/1072, 44 %), O1/O2v2 ( n =353/1072, 33 %), and OL101 ( n =66/1072, 6 %) being the predominant serotypes. The study identified 114 different sequence types (STs) with varying serotypes, with ST231 being the most predominant. O serotypes were strongly linked with STs, with O1/O2v1 predominantly associated with ST231. Simpson’s diversity index and Fisher’s exact test revealed higher serotype diversity in the north and east regions, along with intriguing associations between specific serotypes and resistance profiles. No significant association between KL or O types and disease severity was observed. Furthermore, we found the specific association of virulence factors yersiniabactin and aerobactin ( P 0.05). Conventionally described hypervirulent clones (i.e. KL1 and KL2) in India lacked typical virulent markers (i.e. aerobactin), contrasting with other regional serotypes (KL51). The cumulative distribution of KL and O serotypes suggests that future vaccines may have to include either ~20 KL or four O types to cover >85 % of the carbapenemase-producing Indian K. pneumoniae population. The results highlight the necessity for comprehensive strategies to manage the diverse landscape of K. pneumoniae strains across different regions in India. Understanding regional serotype dynamics is pivotal for targeted surveillance, interventions, and tailored vaccine strategies to tackle the diverse landscape of K. pneumoniae infections across India. This article contains data hosted by Microreact.

Year:

2024

Klebsiella pneumoniae poses a significant healthcare challenge due to its multidrug resistance and diverse serotype landscape. This study aimed to explore the serotype diversity of 1072 K. pneumoniae and its association with geographical distribution, disease severity and antimicrobial/virulence patterns in India. Whole-genome sequencing was performed on the Illumina platform, and genomic analysis was carried out using the Kleborate tool. KL64 (n=264/1072, 26%), KL51 (249/1072, 24%), KL2 (n=88/1072, 8%), O1/O2v1 (n=471/1072, 44%), O1/O2v2 (n=353/1072, 33%), and OL101 (n=66/1072, 6%) were the most prevalent serotypes. The study identified 119 different sequence types (STs) with varying serotypes, with KL64 being the most predominant in ST231 (26%). O serotypes were strongly linked with STs, with O1/O2v1 predominantly associated with ST231 (44%). Simpson’s diversity index and Fisher’s exact test revealed higher serotype diversity in the north and east regions, along with intriguing associations between specific serotypes and resistance profiles. No significant association between KL or O types and disease severity was observed. Furthermore, we found no specific association of virulence factors with KL types or O antigen types (P>0.05). Conventionally described hypervirulent clones (i.e., KL1 and KL2) in India lacked typical virulent markers (i.e., aerobactin), contrasting with other regional serotypes. The cumulative distribution of KL and O serotypes suggests that future vaccines may have to include either ∼20 KL types or 4 O types to cover >85% of the carbapenemase-producing Indian K. pneumoniae population. The findings underscore the need for a vaccine with broad coverage to address the diverse landscape of K. pneumoniae strains in different regions of India. Understanding regional serotype dynamics is pivotal for targeted surveillance, interventions, and tailored vaccine strategies to tackle the diverse landscape of K. pneumoniae infections across India. Data Summary All the sequenced data has been submitted to the European Nucleotide Archive (ENA) under the Bioproject numbers PRJEB29740 and PRJEB50614. Run Accessions and Biosample numbers are provided in Supplementary Table 1 with corresponding metadata for each sample used in the study. The Microreact link for the genomic analysis is provided ( https://microreact.org/project/oqKM84GBszEPW9Emt2FKnP-klebsiella-pneumoniae-indian-serotypes ). The pipelines used in the study are published in gitlab ( https://gitlab.com/cgps/ghru/pipelines ). The tools’ details and the implementation of the pipelines are described in protocols.io ( https://www.protocols.io/view/ghru-genomic-surveillance-of-antimicrobial-resista-bp2l6b11kgqe/v4 ). The R scripts used with all the input files used for each script have been published in Fishare ( https://doi.org/10.6084/m9.figshare.25414807.v1 ) Impact Statement Klebsiella pneumoniae produces polysaccharide capsules, which serve as both epidemiological markers and significant virulence factors. The increasing accessibility of whole genome sequencing has made it easier than ever to investigate this capsule diversity. This study is the first of its kind in India to comprehensively investigate the serotype diversity of K. pneumoniae strains and their association with disease severity, antimicrobial resistance/virulence patterns, and geographical distribution across various regions of the subcontinent. This multi-dimensional analysis not only provides valuable insights into the molecular epidemiology of K. pneumoniae in India but also offers crucial data for the development of targeted interventions, including vaccine formulations tailored to address the prevailing serotypes. These findings serve as a foundation for informed decision-making in the management and prevention of K. pneumoniae infections, ultimately contributing to improved public health outcomes in the region.

Year:

2024

Unified strain taxonomies are needed for the epidemiological surveillance of bacterial pathogens and international communication in microbiological research. Core genome multilocus sequence typing (cgMLST) holds great promise for standardized high-resolution strain genotyping. However, this approach faces challenges including classification instability and disconnection of new nomenclature from widely adopted classical MLST identifiers. This essay discusses the cgMLST-based Life Identification Number (LIN) method, recently proposed as a stable multilevel strain taxonomy system applicable to most bacterial pathogens. We describe how LIN codes are implemented and used in practice for precise strain definitions and epidemiological tracking. Glossary Multilocus sequence typing (MLST) A genotyping method applied mostly to microbial strains to study population structure and epidemiology, based on comparing the nucleotide sequences of a small number (typically seven) of housekeeping protein-coding genes. In MLST, allele numbers are assigned to each sequence variant (allele) of a given gene. The MLST genotype of a bacterial strain is defined by the combination of the allele numbers observed at the genes that are included in the genotyping scheme. A sequence type (ST) is assigned to each unique combination of alleles, called an MLST profile. MLST was invented in 1998 and became a de-facto standard taxonomy of bacterial strains, albeit at low resolution. Core genome MLST An extension of MLST that analyzes sequence variation across hundreds to thousands of conserved (core) genes, shared by all strains of a species, providing higher resolution typing for genomic epidemiology and evolutionary studies. cgMLST schemes typically comprise 2000 to 4000 genes, depending on the genome size and genetic variation (in terms of presence/absence of genes) within bacterial species. A core genome sequence type (cgST) can be assigned to unique cgMLST profiles, i.e., a unique combination of cgMLST allelic numbers. Whole Genome Sequencing (WGS) A method that determines the complete DNA sequence of an organism’s genome in a single process, providing comprehensive information for comparative genetic analyses based on cgMLST or other analytic methods. Single Nucleotide Polymorphisms (SNPs) Variations at a single base position in the DNA sequence among individuals isolates, strains or species, used as genetic markers for studying for example, evolutionary relationships or strain identity. Average nucleotide identity (ANI) A measure of genomic similarity between two organisms, calculated as the average percentage of identical nucleotides in orthologous genomic regions; commonly used to assess species-level relatedness in prokaryotes. Taxonomy Here, we apply the word taxonomy to bacterial strains as a system of classifying, naming and identifying strains based on shared genetic characteristics as defined by e.g., cgMLST.

Year:

2024

Background Candida auris is a globally emerging fungal pathogen that causes nosocomial invasive infections, particularly in intensive care units (ICU). Four prominent genetic clades originating from distinct geographic regions have been identified: South Asia (Clade I), East Asia (Clade II), Africa (Clade III) and South America (Clade IV) with each clade presenting differing antifungal resistance profiles. We aimed to elucidate the epidemiology of this infection in the United Kingdom (UK) 2014 - 2019 using genomic approaches. Methods Genome sequences from 24 isolates from six patients in four London hospitals were combined with genome sequences from 183 additional outbreak isolates from nine UK hospitals. These data were used to assess the numbers and timings of C. auris lineage introductions into the UK and to infer subsequent patterns of inter- and intra-hospital transmission. Findings We found evidence for at least three introductions of C. auris into the UK, one from Clade I and one from Clade III. The evolutionary rate of C. auris Clade I and Clade III were estimated at 2.764 x 10 -4 and 3.186 x 10 -4 substitutions per polymorphic site per year, respectively, with entry into the UK as 2013 and 2016 for Clades I and III respectively. We observed temporal and geographical evidence for multiple transmission events between hospitals and identified local within-hospital patient-to-patient transmission events. Interpretation These data confirm that C. auris is a newly emerged infection in the UK with at least three original introductions into this country. Our analysis shows that hospital outbreaks are linked and confirms that transmission amongst patients has occurred, explaining local hospital outbreaks. Our findings argue that enhanced surveillance of C. auris infection within the UK is necessary in order to protect healthcare and to curtail expansion of this emerging infection. Funding This work was supported by a Wellcome Trust Institutional Strategic Support Fund Springboard Fellowship, and by the Medical Research Council (MR/R015600/1), the Natural Environment Research Council (NE/P001165/1) and the Wellcome Trust (219551/Z/19/Z). Research in context Since its first description in 2009, Candida auris has spread across the globe. For this study, authors considered all publications describing whole genome sequences of isolates within the UK up until 2020 to assess the genomic epidemiology of this fungal pathogen. This study adds value to the current understanding of C. auris epidemiology by undertaking the first analysis to assess transmission between and within hospitals using genomic data. We also provide the first in-depth temporal analysis to estimate likely times of introduction into the UK. These results have clinical implications, encouraging hospitals to identify yeast upon admission and to assess multiple isolates from single patients, which may harbour much diversity in terms of genetics and drug resistance.

Year:

2024

Collaborators (57)

Paul Turner

University of Oxford

UNITED KINGDOM
View details

Ørjan Samuelsen

Professor

UiT The Arctic University of Norway

NORWAY
View details

Helena Seth-Smith

Co-Leader of Microbial Genomics Devision

University of Zurich

SWITZERLAND
View details

Nicole Stoesser

Associate Professor

University of Oxford

UNITED KINGDOM
View details

Amy Mathers

Professor

University of Virginia

UNITED STATES
View details

Alexis Criscuolo

Université Paris-Saclay

FRANCE
View details

David Eyre

Professor of Infectious Diseases

University of Oxford

UNITED KINGDOM
View details

Michael Bachman

Assistant Professor

University of Michigan

UNITED STATES
View details

francesco pomilio

Head of Unit

Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche

ITALY
View details

Ayorinde Afolayan

Bioinformatician (Phylogenomics)

Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures

GERMANY
View details

Sandra Reuter

Research Group Leader

University Medical Center Freiburg

GERMANY
View details

Benjamin P. Howden

-

AUSTRALIA
View details

Koji Yahara

Group Leader

National Institute of Infectious Diseases

JAPAN
View details

Arnfinn Sundsfjord

-

NORWAY
View details

Alexandra Chiaverini

Ricercatore Sanitario (Cat. DS6) Veterinario

Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche

ITALY
View details

Sam Lipworth

University of Oxford

UNITED KINGDOM
View details

Andrew McArthur

Professor

McMaster University

CANADA
View details

M. Estée Török

University of Cambridge

UNITED KINGDOM
View details

Charlene Rodrigues

Assistant Professor in Microbial Genomics

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Adrian Egli

Professor

University of Zurich

SWITZERLAND
View details

Kathryn Holt

Professor (Research)

MONASH UNIVERSITY

AUSTRALIA
View details

Leah Wendy Roberts

Queensland University of Technology

AUSTRALIA
View details

Daniela Maria Cirillo

Head of Unit

Ospedale San Raffaele

ITALY
View details

Alireza Abdolrasouli

Imperial College London

UNITED KINGDOM
View details

Tommaso Giani

Associate Professor

University of Florence

ITALY
View details

Teresa M. Coque

-

SPAIN
View details

Erkison Odih

Københavns Universitet

DENMARK
View details

Marianne Sunde

Norwegian Veterinary Institute

NORWAY
View details

Gian Maria Rossolini

Professor

University of Florence

ITALY
View details

M. C. J. Maiden

University of Oxford

UNITED KINGDOM
View details

Jukka Corander

University of Oslo

NORWAY
View details

Motoyuki Sugai

-

JAPAN
View details

Melanie Hennart

Institut Pasteur

FRANCE
View details

Susana Campino

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Matthew Fisher

Imperial College London

UNITED KINGDOM
View details

Iren H. Löhr

Stavanger University Hospital

NORWAY
View details

D. Sassera

University of Pavia

ITALY
View details

Stephen Baker

University of Cambridge School of Clinical Medicine

UNITED KINGDOM
View details

Kelly L Wyres

MONASH UNIVERSITY

AUSTRALIA
View details

Hugh Gifford

NIHR Clinical Lecturer

University of Exeter

UNITED KINGDOM
View details

Andrea Spitaleri

Researcher

Human Technopole

ITALY
View details

Norelle Sherry

Deputy Director

University of Melbourne

AUSTRALIA
View details

Eva Heinz

Senior Lecturer

University Of Strathclyde

UNITED KINGDOM
View details

Melese Hailu Legese

Lecturer

Uppsala Universitet Uppsala biomedicinska centrum

SWEDEN
View details

Marisa Haenni

-

FRANCE
View details

Johanna Rhodes

Assistant professor

University of Birmingham

UNITED KINGDOM
View details

Sylvain Brisse

Université Paris Cité

FRANCE
View details

Edward Feil

Professor at Department of Life Sciences

University of Bath

UNITED KINGDOM
View details

Patrick N. A. Harris

University of Queensland

AUSTRALIA
View details

Taane Clark

Professor of Genomics and Global Health

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Claire Gorrie

University of Melbourne

AUSTRALIA
View details

Joao Perdigao

Professor do ensino Básico e Secundário

Ministério da Educação

PORTUGAL
View details

Shizuo Kayama

National Institute of Infectious Diseases

JAPAN
View details

Keith Jolley

Bioinformatician

University of Oxford

UNITED KINGDOM
View details

Nicholas Thomson

Head of Programme

Wellcome Sanger Institute

UNITED KINGDOM
View details

Harry Thorpe

University of Oslo

NORWAY
View details

Nicholas Feasey

Professor

Liverpool School of Tropical Medicine

UNITED KINGDOM
View details